RT Book, Section
A1 Ozsari, Levent
A1 Busaidy, Naifa L.
A1 Habra, Mouhammed A.
A2 Kantarjian, Hagop M.
A2 Wolff, Robert A.
SR Print(0)
ID 1126746261
T1 Endocrine and Metabolic Complications of Cancer Therapy
T2 The MD Anderson Manual of Medical Oncology, 3e
YR 2016
FD 2016
PB McGraw-Hill Medical
PP New York, NY
SN 9780071847940
LK accessmedicine.mhmedical.com/content.aspx?aid=1126746261
RD 2024/04/24
AB In  the  past  two  decades,  cancer  research  has  rapidly  advanced,  spurred  by  the  development  of  high-throughput  technology  and  the  maturation  of  genomic  and  proteomic  research  methods.  These  advances  have  resulted  in  treatments  that  have  substantial  effects  on  the  outcomes  of  certain  cancers.  The  continuous  development  of  new  antineoplastic  agents  adds  increasing  challenges  for  practicing  physicians.